This study has successfully demonstrated how the integration of explainable AI, machine learning models, and genetic algorithms can enhance the prediction of bioactivity and ADMET properties of compounds targeting estrogen receptor alpha (ERα) in breast cancer therapy. Here, ESR1 is linked to breast carcinoma.